News & Perspective

Jun 03, 2015

Jun 03, 2015

News Scan for Jun 03, 2015

Vets and animal antibiotics
More anthrax shipments
H5 avian flu in Ghana
Novel bunyaviruses

Jan 29, 2015

Jan 29, 2015

News Scan for Jan 29, 2015

Flu vaccine in Canada
Egypt's H5N1 spike
H7N9 in China
Camera monitors in CDC labs

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Oct 09, 2012

Oct 09, 2012

Experts ponder H5N1 research moratorium issues

(CIDRAP News) – The moratorium on research leading to more-transmissible H5N1 avian influenza viruses, originally set for 60 days, has remained in place for 8 months without a clear end in sight, but a series of commentaries in mBio today from experts familiar with the issues offers some clues for possible next steps.

Jun 26, 2012

Jun 26, 2012

Tests reveal high-path H7N3 in Mexican poultry farm outbreaks

(CIDRAP News) – Mexican veterinary authorities are intensifying avian influenza control efforts in a region that houses several large commercial farms after further tests determined that the strain responsible for more than 200,000 bird deaths at three farms is the highly pathogenic H7N3 subtype.

The events represent the first highly pathogenic avian influenza outbreaks in Mexican flocks since the country battled H5N2 in the mid 1990s.

Feb 01, 2012

May 04, 2009

May 04, 2009

Flu virus's likely human-to-swine jump triggers concern

(CIDRAP News) – The tentative detection of the novel swine influenza H1N1 virus in an Alberta swine herd over the weekend shook Canada's pork industry and raised concern about the potential for new hybrid viruses to emerge.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»